Short anti-TB regimen gets global nod as trials ‘positive’ | India News
MUMBAI: A short tuberculosis treatment regimen of six months called BPaL as against the usual 18-month protocols has won the scientific vote with trials in multiple countries showing it had "favourable outcomes" in 84% to 94% of the…